30. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann.
Neurol. 32, 804 812.
31. Fridovich I. (1993) Superoxide radical and superoxide dismutase. A. Rev. Biochem. 64, 97 112.
32. Gerlach M., Ben-Shachar D., Riederer P. and Youdim M. B. (1994) Are brain metabolism of iron as a cause of
neurodegenerative disease? J. Neurochem. 63, 793 807.
33. Graham D. G. (1984) Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity
and Parkinson's disease. Neurotoxicology fi, 83 95.
34. Hall E. D. (1991) Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders. Ann. Neurol.
32 Suppl., S137-S142.
35. Halliwell B. and Gutteridge J. M. C. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem.
J. 219, 1 14.
36. Halliwell B. and Gutteridge J. M. C. (1989) Free Radieals in Biolog) and Medicine. Calderon Press, Oxford.
37. Hill J. M. (1988) The distribution of iron in the brain. In Brain Iron Chemical and Behavioural Aspects (ed. Youdim
M. B. H.), pp. 1 24. Taylor and Francis, London.
38. Hirsche E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and alumina increase in substantia nigra
of patients with Parkinson's disease: an x-ray microanalysis. J. Neurochem. 56, 446-451.
39. Hong J. S., Hung C. C., Seth P. K., Mason G. and Bondy S. C. (1984) Effect of manganese treatment on the levels
of neurotransmitters, hormones, and neuropeptides: modulation by stress. Environ. Res. 34, 242-249.
40. Jenner P. and Olanow C. W. (1996) Oxidative stress and pathogenesis of Parkinson's disease. Neurobiology 47 Suppl.,
S160 S170.
41. Kikugawa K., Kato T., Beppu M. and Hayasaka A. (1989) Fluorescence and cross-linked proteins formed by free
radicals and aldehyde specifics generated during lipid peroxidation. Adv. exp. med. Biol. 266, 345 356.
42. Lai C. T., Zuo D. M. and Yu P. H. (1994) ls brain superoxide dismutase activity increased following chronic treatment
with 1-deprenyl? J. neural Transm. 41 Suppl., 221 229.
43. Liccione J. J. and Maines M. D. (1988) Selective vulnerability of glutathione metabolism and cellular defense
mechanisms in rat striatum to manganese. J. Pharmac exp. Ther. 247, 156-161.
44. Lloyd R. (1995) Mechanism of the manganese-catalyzed autoxidation of dopamine. C/wm. Res. Toxicol. 8, 11l-116.
45. Lu C.-S., Huang C.-C., Chu N.-S. and Calne D. B. (1994) Levodopa failure in chronic manganism. Neurology 44,
1600 1602.
46. Malecki E. A. and Greger J. L. (1996) Manganese protects against mitochondrial lipid peroxidation in rats fed with
high levels of polyunsaturated fatty acids. ,L Nutr. 126, 27--33.
47. Minotti G. and Aust S. D. (1987) An investigation into the mechanism of citrate-Fe2+-dependent lipid peroxidation.
Free Radio. Biol. Meal 3, 379 387.
48. Mochizuki H., Imai H., Endo K., Yokomizo K., Murata Y., Hattori N. and Mizuno Y. (1994) Iron accumulation in
the substantia nigra of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.
Neurosci. Lett. 168, 252 253.
49. Mohanakumar K. P., De Bartolomeis A., Wu R.-M., Yeh K. J., Sternberger L. M., Peng S.-Y., Murphy D. L. and
Chiueh C. C. (1994) Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid
peroxidation. Ann. N. E Acad. Sci. 738, 392 399.
50. Nachtman J. P., Delor S. and Brennan E. (1987) Manganese neurotoxicity: effects of varying oxygen tension and
EDTA on dopamine auto-oxidation. Neurotoxicology 8, 249-254,
51. Nakamura K., Oliver C. and Stadtman E. R. (1985) Inactivation of glutamine synthetase by a purified rabbit liver
microsomal cytochrome p-450 system. Archs Biochem. Biophys. 240, 319-329.
52. Olanow C. W., Good P. F., Sinotoh H., Hewitt K. A., Vingerhoets F., Snow B. J., Beal M. F., Calne D. B. and Perl
D. P. (1996) Manganese intoxication in rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
Neurology 46, 492~,98.
53. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M. and Floyd R. A. (1990) Oxidative damage
to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusioninduced injury to gerbil brain. Proc. natn. Acad. Sci. U.S.A. 87, 5144 5147.
54. Papavasiliou P. S., Kutt H., Miller S. T., Rosal V., Wang Y. Y. and Aronson R. B. (1979) Seizure disorders and trace
metals: manganese tissue levels in treated epileptics. Neurology 29, 1466-1473.
55. Parenti M., Rusconi L., Cappabianca V. M., Parati E. A. and Gropetti A. (1988) Role of dopamine in manganese
neurotoxicity. Brain Res. 473, 236-240.
56. Paxinos G. and Watson C. (1986) The Rat Brain hi Stereotaxic Coordinates, 2nd edn, Academic, San Diego.
57. Rauhala P., Szirfiki I. and Chiueh C. C. (1996) Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl
radicals. Free Rad. Biol. Med. 21,391-394.
58. Rojas P. and Rios C. (1995) Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-l,2,3,6- tetrahydropyridine neurotoxicity. Neurochem. Res. 20, 1217-1223.
59. Sengstock G. J., Olanow C. W., Menzies R. A., Dunn A. J. and Arendash G. W. (1993) Infusion of iron into the rat
substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers, dl Neurosci. Res. 35,
67 -82.
60. Shimasaki H. (1994) Assay of fluorescent lipid peroxidation products. Meth. Enzym. 233, 338-346.
61. Shinotoh H., Snow B. J., Hewitt K. A., Pate B. D., Doudet D., Nugent R., Perl D. P., Olanow W. and Calne D. M.
(1995) MRI and PET studies of manganese-intoxicated monkeys. Neurology 45, 1199 1204.
62. Shinotoh H., Snow B. J., Chu N. S., Huang C. C., Lu C. S., Lee C., Takahashi H. and Calne D. B. (1997) Presynaptic
and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission
tomography study. Neurology 48, 1053 1056.
63. Shukla G. S. and Chandra S. V. (1981) Manganese toxicity: lipid peroxidation in rat brain. Aeta Pharmac. Toxicol. 48,
95-100.
64. Sloot W. N., Korf J., Koster J. F., DeWit L. E. and Gramsgergen J. B. (1996) Manganese-induced hydroxyl
radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Expl Neurol. 138,
236 245.
